XML 21 R6.htm IDEA: XBRL DOCUMENT v3.7.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
 12 Months Ended
Apr. 01, 2017
Apr. 02, 2016
Mar. 28, 2015
Cash flows from operating activities:      
Net income (loss) $ (99.3) $ 396.4 $ 702.2
Adjustments to reconcile net income (loss) to net cash provided by operating activities:      
Depreciation and amortization expense 307.5 309.4 294.4
Deferred income tax expense (benefit) (38.9) (7.9) 10.5
Equity in loss of equity-method investees 5.2 10.9 11.5
Non-cash stock-based compensation expense 63.6 97.0 80.5
Asset Impairment Charges 253.8 48.8 6.9
Non-cash restructuring-related inventory charges 197.9 20.4 0.0
Excess tax benefits from stock-based compensation arrangements (0.3) (10.2) (7.7)
Other non-cash charges (benefits) 29.2 19.7 (24.6)
Changes in operating assets and liabilities:      
Accounts receivable 54.1 129.4 (95.6)
Inventories 120.4 (90.9) (97.5)
Prepaid expenses and other current assets (27.8) 30.2 (96.5)
Accounts payable and accrued liabilities 112.9 90.1 50.3
Income tax receivables and payables (34.0) (14.6) (22.2)
Deferred income (20.7) (7.9) (21.1)
Other balance sheet changes 28.7 (14.3) 102.2
Net cash provided by operating activities 952.3 1,006.5 893.3
Cash flows from investing activities:      
Capital expenditures (284.0) (417.7) (391.2)
Purchases of investments (860.4) (1,085.0) (1,397.7)
Proceeds from sales and maturities of investments 942.4 942.7 1,112.8
Acquisitions and ventures (6.1) (16.3) (11.7)
Change in restricted cash deposits 0.3 (6.0) (0.9)
Net cash used in investing activities (207.8) (582.3) (688.7)
Cash flows from financing activities:      
Proceeds from issuance of short-term debt 3,735.2 4,343.9 2,807.7
Repayments of short-term debt (3,851.3) (4,462.6) (2,573.8)
Proceeds from issuance of long-term debt 0.0 299.4 0.0
Payments of capital lease obligations (27.3) (24.3) (23.9)
Payments of dividends (164.8) (170.3) (158.2)
Repurchases of common stock, including shares surrendered for tax withholdings (215.2) (500.4) (531.6)
Proceeds from exercise of stock options 5.0 33.2 52.5
Excess tax benefits from stock-based compensation arrangements 0.3 10.2 7.7
Other financing activities 0.0 (1.9) (1.0)
Net cash used in financing activities (518.1) (472.8) (420.6)
Effect of exchange rate changes on cash and cash equivalents (14.4) 5.2 (81.7)
Net increase (decrease) in cash and cash equivalents 212.0 (43.4) (297.7)
Cash and cash equivalents at beginning of period 456.3 499.7 797.4
Cash and cash equivalents at end of period $ 668.3 $ 456.3 $ 499.7